December 31, 2012

CAS databases provide millions of journal article references from more than 10,000 major scientific journals worldwide, patent and patent family references from 63 patent authorities around the world, and other reputable web sources.  

The following patent record is from the CAplusSM database.

CAPLUS COPYRIGHT 2012 ACS

Patent Number: WO 2012143813
Title: Preparation of spiro[indazole-5,4'-piperidin]-1'-yl compounds as acetyl-CoA carboxylase inhibitors
Inventor(s): Dow, Robert Lee; Edmonds, David James; Griffith, David Andrew; Southers, James Alfred, Jr.
Patent Assignee(s): Pfizer Inc., USA
Source: U.S. Pat. Appl. Publ., 73pp. CODEN: USXXCO
Language: English

Abstract:

Title compds. I and II [R1 = alkyl or cylcoalkyl; R2 = (un)substituted indolyl, indazolyl, pyrrolopyridinyl, pyrazolopyridinyl, quinolinyl or benzoimidazolyl; R3 = H or alkyl], and their pharmaceutically acceptable salts, are prepared as acetyl-CoA carboxylase (ACC) inhibitors. Thus, e.g., compound III was prepared by the coupling reaction of 1-isopropyl-4,6-dihydrospiro[indazole-5,4'-piperidin]-7(1H)-one (preparation given) with 3-carbamoyl-1H-indole-6-carboxylic acid (preparation given). Compound III exhibited  inhibitory activity against recombinant human ACC1 and ACC2 with IC50 values of 6.0 nM and 1.4 nM, resp. The  invention compds. are useful for the treatment of acetyl-CoA carboxylase associated diseases such as type 2 diabetes and nonalcoholic fatty liver disease (NAFLD).

View the full-text patent here.

Note: Abstracts and Titles for patent records in CAplus are routinely enhanced to better describe the claimed invention. In this example, CAS enhanced the abstract using additional information found in the patent. The title of the PCT patent publication is Substituted acetyl-CoA carobxylase inhibitors.

Recent News

       
    February 9, 2015 | Major New STN Release Delivers
    Essential Biomedical and Patent Content to IP
    Professionals
    
    January 26, 2015
 | Annual MEDLINE Reload on STN
    Features Enhanced Clinical Trial Information and the
    2015 MeSH Thesaurus
    
    January 23, 2015
 | STN Launches New Pricing
    Option for Information Brokers: Search Service
    Value Pricing
                               
  
                                                                     More News >> 

 Media Contact

 Name: Rhonda Ross
 Phone: 614-447-3624                                       
 Email: cas-pr@cas.org